IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 142 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,098,000 | -45.2% | 395,574 | -2.4% | 0.29% | -28.6% |
Q3 2018 | $7,480,000 | -24.9% | 405,224 | -22.2% | 0.41% | -32.3% |
Q2 2018 | $9,959,000 | +41.5% | 520,888 | +14.2% | 0.60% | +18.1% |
Q1 2018 | $7,038,000 | +20.0% | 456,100 | +16.6% | 0.51% | +10.2% |
Q4 2017 | $5,864,000 | -14.7% | 391,200 | -10.3% | 0.46% | -19.7% |
Q3 2017 | $6,876,000 | +4.0% | 436,000 | +24.5% | 0.57% | -5.7% |
Q2 2017 | $6,610,000 | +10.7% | 350,096 | -0.0% | 0.61% | +1.7% |
Q1 2017 | $5,973,000 | -72.3% | 350,107 | -75.1% | 0.60% | -19.1% |
Q4 2016 | $21,528,000 | -3.7% | 1,408,000 | 0.0% | 0.74% | +1.1% |
Q3 2016 | $22,359,000 | +51.5% | 1,408,000 | +24.7% | 0.73% | +36.1% |
Q2 2016 | $14,762,000 | +299.7% | 1,129,000 | +389.2% | 0.54% | +407.5% |
Q1 2015 | $3,693,000 | – | 230,800 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |